Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited)

v3.20.1
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement of Cash Flows [Abstract]    
Net Loss $ (31,371) $ (260,286)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of ReadyOp software platform 10,878 32,598
Amortization of ReadyOp customer list 8,046
Amortization of ReadyMed software platform 85,032
Provision (Recovery) for bad debt (13,335) 8,000
(Increase) decrease in assets:    
Accounts receivable 116,201 (43,195)
Inventory 4,732 (12,828)
Prepaid expenses and other current assets 23,656
Assets from discontinued operations 9,929 (20,464)
Increase (decrease) in liabilities:    
Accounts payable (47,216) 10,500
Accrued expenses (55,471) (56,169)
Deferred revenue (30,382) 118,792
Customer deposit 14,000
Liabilities from discontinued operations 2,486 73,256
Net Cash Provided by (Used in) Operating Activities 75,139 (127,750)
Cash Flows From Investing Activities    
Issuance of note receivable - discontinued operations 25,000
Repayment of note receivable - discontinued operations (25,000)
Net Cash Used in Investing Activities
Cash Flows From Financing Activities    
Proceeds from issuance of installment loan-discontinued operations 43,600 43,810
Repayment of installment loan - discontinued operations (33,151) (14,550)
Proceeds from notes payable 50,000
Repayment of note payable (50,000)
Repayment of notes payable stockholders (14,709)
Proceeds from loan payable - related party - discontinued operations 11,362
Proceeds from issuance of Common Stock 100,000
Net Cash Provided by Financing Activities 7,102 129,260
Net Increase In Cash 82,241 1,510
Cash at beginning of period 27,698 413
Cash at end of period 109,939 1,923
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 4,433
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Operating lease asset obtained for operating lease liability from discontinued operations 75,078
Common stock issued for ReadyMed Platform 600,000
Deconsolidation of Voiceinterop, Inc. $ 225,316